Cancer :: Aspirin use, but not NSAIDS, associated with reduced cancer risk
In a prospective study, aspirin use was associated with lower risk of cancer incidence and mortality, particularly among former and non-smokers.
Heart Disease
Bipolar Disorder :: Comorbidities common in bipolar disorder, may have genetic link
While the symptoms of bipolar disorder can be disabling on their own, most patients with the condition also are afflicted with a variety of other psychiatric, substance use and physical disorders.
Diabetes :: FDA approves Continuous 7-Day Glucose Monitoring System
The U.S. Food and Drug Administration today approved a device that measures glucose levels continuously for up to seven days in people with diabetes.
Trans Fat :: Pan American Health calls for trans fat free Americas
The Pan American Health Organization (PAHO), a regional arm of the United Nations World Health Organization (WHO), called for the elimination of industrial trans fats from food supplies throughout the Americas in order to prevent heart attacks.
Diabetes :: New drug protects against diabetes and atherosclerosis
Blocking a single protein with an experimental drug prevented and treated both type 2 diabetes and atherosclerosis in laboratory mice that had been fed unhealthy diets and were genetically predisposed to these common killers, according to an article published online at Nature on June 6, 2007.
Rheumatoid Arthritis :: University of Manchester researchers reveal clues to new genes behind rheumatoid arthritis
Researchers at the University of Manchester have identified evidence of several new genes behind the chronic inflammatory disease rheumatoid arthritis (RA), which affects 387,000 people in the UK.
Heart disease :: Heart disease deaths fall, as obesity and diabetes increase, experts find
Epidemiologists at the University of Liverpool and the Heart of Mersey have found that approximately half the recent fall in coronary heart disease deaths in the US is due to positive life style changes and a further half to medical therapies.
Avandia :: Newly published data from large study support cardiovascular safety of Avandia
A study of more than 33,000 type 2 diabetes patients in a real-world setting was published today. This study shows that the incidence of hospitaliations for heart attack, and/or for a surgery known as coronary revascularization for patients on Avandia is the same as for other diabetes treatments.
Metabolic Syndrome :: Metabolic syndrome points to heart health
Typified by high blood pressure, weight gain around the waist and problems regulating blood sugar, metabolic syndrome may also be associated with compromised heart structure and function, according to a paper published in the online open access journal BMC Cardiovascular Disorders.
Diabetes :: American Diabetes Association strongly advises patients using rosiglitazone to see their doctor
On June 5, 2007, the New England Journal of Medicine published results of an interim analysis of the cardiovascular safety trial of rosiglitazone (brand name, Avandia).